TP53 Mutated AML: Transplant or No Transplant
October 11, 2024
In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.”BUFFALO, NY- October 11, 2024 – A new editorial was published in... read more